NEU neuren pharmaceuticals limited

Ann: DAYBUE Q1 2025 net sales US$84.6m up 11% from Q1 2024, page-6

  1. 24 Posts.
    lightbulb Created with Sketch. 18
    What we knew all along. This product is bring so much benefits to the lives of those families. It’s always hard to adjust and sometimes it feels like no progress is being made. We need to appreciate the families and the medical staff who have supported the families through the transition onto Daybue.

    This is just recognition of what management (Jon and others) have been telling the market for the last 2 years. The market has a choice and they just didn’t want to listen.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.96
Change
-0.140(1.07%)
Mkt cap ! $1.612B
Open High Low Value Volume
$13.20 $13.36 $12.82 $4.627M 354.8K

Buyers (Bids)

No. Vol. Price($)
1 7585 $12.96
 

Sellers (Offers)

Price($) Vol. No.
$13.03 3344 2
View Market Depth
Last trade - 16.10pm 16/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.